These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12932676)

  • 1. Differential relationship between changes in tumour size and microcirculatory functions induced by therapy with an antivascular drug and with cytotoxic drugs. implications for the evaluation of therapeutic efficacy of AC7700 (AVE8062).
    Hori K; Saito S; Sato Y; Akita H; Kawaguchi T; Sugiyama K; Sato H
    Eur J Cancer; 2003 Sep; 39(13):1957-66. PubMed ID: 12932676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular mechanisms by which the combretastatin A-4 derivative AC7700 (AVE8062) induces tumour blood flow stasis.
    Hori K; Saito S
    Br J Cancer; 2003 Oct; 89(7):1334-44. PubMed ID: 14520469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs.
    Hori K; Saito S; Kubota K
    Br J Cancer; 2002 May; 86(10):1604-14. PubMed ID: 12085211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects due to irreversible stoppage of tumor tissue blood flow: evaluation of a novel combretastatin A-4 derivative, AC7700.
    Hori K; Saito S; Nihei Y; Suzuki M; Sato Y
    Jpn J Cancer Res; 1999 Sep; 90(9):1026-38. PubMed ID: 10551334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tumour blood flow stasis and necrosis: a new function for epinephrine similar to that of combretastatin A-4 derivative AVE8062 (AC7700).
    Hori K; Saito S
    Br J Cancer; 2004 Jan; 90(2):549-53. PubMed ID: 14735207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stoppage of blood flow in 3-methylcholanthrene-induced autochthonous primary tumor due to a novel combretastatin A-4 derivative, AC7700, and its antitumor effect.
    Hori K; Saito S; Sato Y; Kubota K
    Med Sci Monit; 2001; 7(1):26-33. PubMed ID: 11208488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic strategy: irreversible tumor blood flow stasis induced by the combretastatin A-4 derivative AVE8062 (AC7700).
    Hori K
    Chemotherapy; 2005 Oct; 51(6):357-60. PubMed ID: 16227690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor blood flow interruption after radiotherapy strongly inhibits tumor regrowth.
    Hori K; Furumoto S; Kubota K
    Cancer Sci; 2008 Jul; 99(7):1485-91. PubMed ID: 18452559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Siim BG; Lee AE; Shalal-Zwain S; Pruijn FB; McKeage MJ; Wilson WR
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):43-52. PubMed ID: 12497205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Starvation tactics for solid tumors: tumor blood flow interruption via a combretastatin derivative (Cderiv), and its microcirculation mechanism.
    Hori K
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):109-22. PubMed ID: 22101805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin versus mitomycin versus doxorubicin plus mitomycin in advanced breast cancer: a randomized study.
    Andersson M; Daugaard S; von der Maase H; Mouridsen HT
    Cancer Treat Rep; 1986 Oct; 70(10):1181-6. PubMed ID: 3530444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of combretastatin A4 phosphate and doxorubicin-containing liposomes affects growth of B16-F10 tumors.
    Mitrus I; Sochanik A; CichoĊ„ T; Szala S
    Acta Biochim Pol; 2009; 56(1):161-5. PubMed ID: 19287800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
    Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
    Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor microcirculation and selective enhancement of drug delivery--clinical applications based on pathophysiological experiments].
    Sato H; Hori K; Sugiyama K; Tanda S; Sato Y
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1191-200. PubMed ID: 10945016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
    Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2263-70. PubMed ID: 1929447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of intra-arterial chemotherapy combined with degradable starch microspheres against liver cancer--a study by experimental VX2 liver tumor model].
    Yoshikawa T; Itani K; Kokura S; Oyamada H; Kondo M
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1803-9. PubMed ID: 8379673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding a reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts.
    Arvelo F; Poupon MF; Bichat F; Grossin F; Bourgeois Y; Jacrot M; Bastian G; Le Chevalier T
    Eur J Cancer; 1995 Oct; 31A(11):1862-8. PubMed ID: 8541114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of vascular-disrupting agents in Ewing's sarcoma family of tumours.
    Dalal S; Burchill SA
    Eur J Cancer; 2009 Mar; 45(4):713-22. PubMed ID: 19136249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.